A pilot, controlled, randomized trial of life logy as a new complementary and alternative medicine technique in patients with fibromyalgia syndrome
Keywords:Fibromyalgia, Complementary and alternative medicine, Life logy
Background: Fibromyalgia syndrome (FMS) is a complex disorder, with primary symptoms of pain and fatigue. No cure for FM yet exists and treatments have been largely disappointing. In most cases complementary and alternative medicine (CAM) is used adjunctively to allopathic medicine. The present study aimed to evaluate the analgesic efficacy of sessions of life logy technique as well as patients’ physical and mental improvement on patients with fibromyalgia.
Methods: Fibromyalgia patients were recruited from a private CAM center in Beirut, Lebanon from May to June 2017. Eighty patients were included and randomly assigned (1:1) to a treatment and a control groups. Each patient received 5 life logy sessions through 5 weeks and assessed by visual analogue scale, fibromyalgia impact questionnaire and SF-36 at sixth week, third and sixth months follow-up.
Results: The mean visual analog score, functional impairment and quality of life and SF-32 (physical and mental) scores in treatment groups were significantly decreased for time intervals (p=0.003, 0.0034 and 0.003), (p=0.002, 0.001and 0.001), (p=0.003, 0.005 and 0.002) and (p=0.002, 0.001 and 0.004); respectively.
Conclusions: This pilot study suggests that life logy technique is a promising, durable, non-invasive, outpatient and inexpensive technique with a considerable effect on reducing pain and improving life quality in fibromyalgia patients. Further studies on a larger number of patients are needed.
Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547-55.
Cabo-Meseguer A, Cerda-Olmedo G, Trillo-Mata JL. Fibromyalgia: prevalence, epidemiologic profiles and economic costs. Med Clin (Barc). 2017;149(10):441-8.
Butler S, Landmark T, Glette M, Borchgrevink P, Woodhouse A. Chronic widespread pain – the need for a standard definition. Pain. 2016;157(3):541-3.
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160-72.
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken). 2010;62(5):600-10.
Wolfe, F, Clauw D, Fitzcharles M, Goldenberg DL, Häuser W, Katz RL, et al., 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria, Semin Arthritis Rheum. 2016;46(3):319-29.
Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38(1):19-28.
Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken). 2013;65(5):786-92.
Guermazi M, Ghroubi S, Sellami M, Elleuch M, Feki H, André E, et al. Fibromyalgia relevance in Tunisia. Tunis Med. 2008;86(9):806-11.
Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, et al. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat. 2012;2012:426130.
Kim J, Loggia ML, Cahalan CM, Harris RE, Beissner F, Garcia RG, et al. The somatosensory link in fibromyalgia: functional connectivity of the primary somatosensory cortex is altered by sustained pain and is associated with clinical/autonomic dysfunction. Arthritis Rheumatol. 2015;67(5):1395-405.
Cohen H. Controversies and challenges in fibromyalgia: a review and a proposal. Ther Adv Musculoskelet Dis. 2017;9(5):115-27.
Yunus MB. Fibromyalgia and overlapping disorders: the unifying concept of central sensitivity syndromes. Semin Arthritis Rheum. 2007;36(6):339-56.
Choy E. Fibromyalgia Syndrome, 2nd edition. Oxford Rheumatology Library. Oxford: Oxford University Press; 2015.
Jensen KB, Srinivasan P, Spaeth R, Tan Y, Kosek E, Petzke F, et al. Overlapping structural and functional brain changes in patients with long-term exposure to fibromyalgia pain. Arthritis Rheum. 2013;65(12):3293-303.
Ichesco E, Puiu T, Hampson JP, Kairys AE, Clauw DJ, Harte SE, et al. Altered fMRI resting-state connectivity in individuals with fibromyalgia on acute pain stimulation. Eur J Pain. 2016;20(7):1079-89.
Staud R, Weyl EE, Bartley E, Price DD, Robinson ME. Analgesic and anti-hyperalgesic effects of muscle injections with lidocaine or saline in patients with fibromyalgia syndrome. Eur J Pain. 2014;18(6):803-12.
Moldofsky H. The significance, assessment, and management of non-restorative sleep in fibromyalgia syndrome. CNS Spectr. 2008;13(Suppl. 5):22-6.
Ablin JN, Buskila D. Update on the genetics of the fibromyalgia syndrome. Best Pract Res Clin Rheumatol. 2015;29(1):20-8.
Liedberg GM, Bjork M, Borsbo B. Self-reported non-restorative sleep in fibromyalgia-relationship to impairments of body functions, personal function factors, and quality of life. J Pain Res. 2015;8:499-505.
Nibojsa N, Tatiana T, Ivana K, Kenneth C. The role of genetic polymorphisms in chronic pain patients, Int J Mol Sci, 2018;19(6):1707.
Andersson ML, Svensson B, Bergman S. Chronic widespread pain in patients with rheumatoid arthritis and the relation between pain and disease activity measures over the first 5 years. J Rheumatol. 2013;40(12):197-8.
Talotta R, Bazzichi L, Di Franco M, Casale R, Batticciotto A, Gerardi MC, et al. One year in review 2017: fibromyalgia. Clin Exp Rheumatol. 2017;35(Suppl 105):6-12.
McCabe PS, Pye SR, Beth JM, Lee DM, Tajar A, Bartfai G, et al. Low vitamin D and the risk of developing chronic widespread pain: results from the European male ageing study. BMC Musculoskelet Disord. 2016;17:32.
Littlejohn GO, Walker J. A realistic approach to managing patients with fibromyalgia. Curr Rheumatol Rep. 2002;4:286-92.
Terry R, Perry R, Ernst E. An overview of systematic reviews of complementary and alternative medicine for fibromyalgia. Clinical Rheumatology. 2012;31(1):55-66.
Ernst E. Chiropractic treatment for fibromyalgia: a systematic review. Clinical Rheumatology. 2009;28(10):1175-8.
De Silva V, El-Metwally A, Ernst E, Lewith G, Macfarlane GJ. Evidence for the efficacy of complementary and alternative medicines in the management of fibromyalgia: a systematic review. Rheumatology. 2010;49(6):1063-8.
Pinto NDS, Monteiro MDOB, Paiva DN, Santos-Filho SD, Misssailidis S, Thompson D, et al. Fibromyalgia and the relevance of the whole-body vibration exercises in vibratory platforms: a short review. Braz Arch Boil Technol. 2012;55(1):61-7.
Glombiewski JA, Buskila D, Häuser W. Efficacy of EMG- and EEG-biofeedback in fibromyalgia syndrome: a meta-analysis and a systematic review of randomized controlled trials. Evid-Based Comp Altern Med. 2013;2013:11.
Lauche R, Cramer H, Häuser W, Dobos G, Langhorst J. A systematic review and meta-analysis of qigong for the fibromyalgia syndrome. Evid-Based Comp Altern Med. 2013;2013:12.
Gerard E, Dallal PD. 2008. http://www.randomization.com. Last Accessed on 15 July 2019.
Crawford BK, Piault EC, Lai C, Bennett RM. Assessing fibromyalgia-related fatigue: content validity and psychometric performance of the Fatigue Visual Analog Scale in adult patients with fibromyalgia. Clin Exp Rheumatol. 2011;29(6 Suppl 69):534-43.
Rivera J, Gonzalez T. The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol. 2004;22(5):554-60.
Ware J, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: a user’s manual. Boston: Health Assessment Lab; 1994.
Rivera J1, Rejas J, Esteve-Vives J, Vallejo MA, Groupo ICAF. Resource utilization and health care costs in patients diagnosed with fibromyalgia in Spain. Clin Exp Rheumatol. 2009;27(56):S39-45.
Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, Häuser W, Fluß E, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318-28.
Heffez DS, Ross RE, Shade-Zeldow Y, Kostas K, Morrissey M, Elias DA, et al. Treatment of cervical myelopathy in patients with the fibromyalgia syndrome: outcomes and implications. Eur Spine J. 2007;16(9):1423-33.
Rowe PC, Marden CL, Heinlein S, Edwards CC. Improvement of severe myalgic encephalomyelitis/chronic fatigue syndrome symptoms following surgical treatment of cervical spinal stenosis. J Transl Med. 2018;16(1):21.
Vincent A, Whipple MO, Low PA, Joyner M, Hoskin TL. Patients with Fibromyalgia Have Significant Autonomic Symptoms but Modest Autonomic Dysfunction. PMR. 2016;8(5):425-35.